share_log

新興市場銘柄ダイジェスト:サイジニアは一時ストップ高を付け年初来高値を更新、クオリプスがストップ高

Emerging Market Stock Digest: Signia updated its year-to-date high with a temporary stop high, and Qualypse stopped high

Fisco Japan ·  May 28 14:59

<6524> Kohoku Kogyo 2490 +155

Significant continued growth. New multi-core fiber-connected optical components for next-generation submarine cable systems have been developed in collaboration with the KDDI Research Institute, and it has been announced that they are contributing to the demonstration of 18,090 km of optical fiber transmission, which is the longest in the world. Since US Google announced the first optical fiber route “Umoja,” which directly connects Africa and Australia, on 5/24, it is also a timing where interest in undersea cable-related brands is currently growing, and it seems that it is an expected material.

<6031> Signia 928 +123

A temporary stop increase has been added, and the year-to-date high has been updated. It has been announced that the EC product search/site search engine “ZETA SEARCH” of the group company ZETA (Setagaya-ku, Tokyo) has been introduced to the “Sakazen” official online shopping site operated by Sakazen Shoji (Chuo-ku, Tokyo). It is said that narrowed down searches etc. by multiplying “size,” “color,” and “price,” which are used as a reference when purchasing apparel products, are possible, making it easier to find products.

<4894> Qualypus 4400+700

The stop is high. The fact that it was reported that “manufacturing and sales approval will be applied to the Ministry of Health, Labor, and Welfare as early as June” regarding the application period for iPS cell-derived cardiomyocyte sheets continues to be viewed as purchasing material. In the financial results briefing video on the 15th, President Takayuki Kusanagi stated, “Frankly speaking, they say June at the earliest, but the timing is just around the corner.” If approval is applied for, it will be the world's first drug derived from iPS cells, and it seems that expectations are growing in response to reports.

<7776> Cell Seed 271 -3

The year-to-date high price update was also unable to grow, and it fell. Of the stock acquisition rights issued on 23/6/5, it was announced that 7877 (11.42% of the total number issued) were exercised, and 787,700 shares were issued. There are 15,910 unexercised stock acquisition rights. Concerns about future dilution of stock values have receded due to mass exercise. Also, it was reported that Qualypus <4894> will apply to the Ministry of Health, Labor, and Welfare for approval to manufacture and sale of myocardial sheets created from iPS cells in June, and it seems that investors' attention is being drawn to drug discovery ventures.

<5242> Eyes 2167 +400

The stop is high. It has been announced that the number of companies taking the stage at the online seminar event “Media Radar Week” hosted by the advertising industry platform “Media Radar” has exceeded 200 companies. It is an event where marketing experts gather, and it is said that many large companies leading the industry and media management companies are also on stage. Since the eye stock had continued to drop drastically until the day before, it seems that there is also a rush to buy.

<6182> Metalreal 1053 +22

Continued significant growth. Group company Rosetta (Chiyoda-ku, Tokyo) has announced that the cutting-edge large-scale language model “GPT-4O” released by US OpenAI has been mounted on the industry-specific generative AI system “Metareal AI LLM2.” It is said that AI orchestration using 10 LLM groups (GPT-4O, GPT-4, GPT-3.5, Claude3 Opus, Claude3 Sonnet, Claude3 Haiku, Mixtral-8x7b, Gemma7B, Llama 3 70B, Llama 3 8B) will operate together with existing mounted models.

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment